WHO Sounds Warning Over Severe Scarcity of Obesity Jabs
Fewer than 10% of patients eligible to benefit from obesity jabs such as Wegovy have access to them, caution the World Health Organization as it issues its initial recommendations on the medications.
Considering more than one billion individuals worldwide currently classified as obese, it is advocating for increased and just access to this class of drugs.
Based on forecasts, more than two billion are projected to be living with obesity by 2030 if no action is taken.
"Our new guidelines acknowledges that obesity is a long-term condition that can be managed with comprehensive and ongoing support," said WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and supply-chain constraints are key barriers to widespread availability to the jabs that can assist patients in reducing significant body mass, explains the body.
Skinny Jab Supply Crisis
Despite the current most favorable case, the supply of such drugs would only suffice for about 100 million people – fewer than 10% of those who need them, per the health organization.
The recommendation urges nations and manufacturers to expand availability, through measures such as voluntary licensing.
A patent on a key compound – the main component of Novo Nordisk's Wegovy – is set to lapse in several countries in 2026.
How Obesity Jabs Function
The injections mimick a natural hormone to slow digestion, curb appetite and enhance satiety so people reduce food intake.
Individuals commonly start to lose weight in the initial weeks of commencing the weekly injections.
Evidence suggests people may put most of the weight back on a year later of halting the medication, when their typical hunger come back.
Being above a healthy weight elevates your chance for experiencing diseases, such as diabetes, cardiovascular issues, stroke, and some cancers.
Excess weight impacts individuals in every country and was responsible for over three and a half million deaths worldwide in 2024, as per the health agency.
